neostigmine has been researched along with Diseases of Immune System in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| RITTWAGEN, M | 1 |
| ROMANO, FJ | 1 |
| SVIGALS, MP | 1 |
| SCIAGRA, A | 1 |
| NERI SERNERI, GG | 1 |
| MORETTINI, A | 1 |
2 other studies available for neostigmine and Diseases of Immune System
| Article | Year |
|---|---|
A study on the incidence of allergy in children with rheumatic fever.
Topics: Anaphylaxis; Child; Hypersensitivity; Immune System Diseases; Incidence; Infant; Neostigmine; Rheuma | 1946 |
[Inhibition of the Sanarelli-Shwartzman phenomenon by intra-arterial administration of acetylcholine and prostigmine].
Topics: Acetylcholine; Hypersensitivity; Immune System Diseases; Neostigmine; Shwartzman Phenomenon | 1957 |